No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
SMS Lifesciences India Limited is a pharmaceutical enterprise engaged in the manufacturing, sourcing, importing, and distribution of active drug components (APIs) along with their intermediates, various organic and inorganic chemicals, and finished pharmaceutical products across the Indian market. The company's API offerings cater to a range of medical conditions, encompassing therapeutic areas such as antiulcer treatments, antifungal medications, and solutions for erectile dysfunction. Beyond its product line, the firm also provides expert consultancy services. Its reach extends beyond national borders, as it actively exports its diverse product range. Established in 1990, the company's main operations are based in Hyderabad, India.
www.smslife.inNo one on the platform currently holds SMSLIFE.NS.
No tracked institution reports a position in SMSLIFE.NS as of their last filing.
No one on the platform has traded SMSLIFE.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SMSLIFE.NSSMS Lifesciences India Limited | $1299.00 | +0.81% | $3.9B | — |
| BAFNAPH.NSBafna Pharmaceuticals Limited | $309.00 | +0.55% | $7.3B | — |
| GENNEX.BOGennex Laboratories Limited | $10.63 | +5.56% | $2.6B | — |
| LYKALABS.BOLyka Labs Limited | $82.45 | +1.97% | $2.9B | — |
| LYKALABS.NSLyka Labs Limited | $80.11 | -1.40% | $2.9B | — |
| NECLIFE.BONectar Lifesciences Limited | $10.99 | -3.43% | $2.1B | — |
| TAKE.BOTAKE Solutions Limited | $17.79 | -4.56% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry